Synthesis of poly(ethylene glycol)–Metaxalone (cas 1665-48-1) conjugates and study of its controlled release in vitro

Add time:09/26/2019    Source:sciencedirect.com

Metaxalone (Met), a drug for treatment of pain and stiffness due to muscular injuries, was covalently linked to poly(ethylene glycols) (PEG) via a chloroacetyl chloride spacer. The average weight molecular weights used for PEG are 4000, 6000 and 10,000, respectively, and the procedure of chemical modification for PEGs was conducted by a two-step protocol: (1) synthesis of N-chloroacetyl-metaxalone; (2) synthesis of PEG4000–Met, PEG6000–Met and PEG10000–Met. The controlled drug release studies were performed in buffer solutions with pH values equal to 1.1, 7.4 and 10.0. The results demonstrate that, in the same condition, the rate of hydrolysis for PEG10000–Met is the slowest among three prodrugs, and more amount of metaxalone can be detected releasing from prodrug matrices at the presence of α-chymotrypsin in a buffer solution with pH 8.0. It was also found that these novel prodrugs can effectively improve the metaxalone's pharmacokinetics, and furthermore can markedly increase its half-life period.

We also recommend Trading Suppliers and Manufacturers of Metaxalone (cas 1665-48-1). Pls Click Website Link as below: cas 1665-48-1 suppliers

Prev:Short communicationMetaxalone (cas 1665-48-1) estimation in biological matrix using high-throughput LC–MS/MS bioanalytical method
Next:Solubilities of chlormezanone, Metaxalone (cas 1665-48-1) and methocarbamol in supercritical carbon dioxide)